| | |
Predicted Mortality Probability as Percentage
| | |
|---|
|
Model
|
Range
|
10th percentile
|
25th percentile
|
50th percentile
|
75th percentile
|
90th percentile
|
Mean
|
SD
|
|---|
|
Lymph Node Evaluation + Radiologic Imaging (Base Model)
|
22–69
|
22
|
22
|
22
|
38
|
69
|
33
|
14
|
|
Base Model + Continuous E-cadherin
|
9–87
|
15
|
21
|
29
|
41
|
60
|
33
|
17
|
|
Base Model + E-cadherin Dichotomized at 0.52
|
20–79
|
20
|
20
|
35
|
35
|
69
|
33
|
17
|
|
Base Model + E-cadherin Dichotomized at 0.60
|
19–93
|
19
|
19
|
33
|
40
|
67
|
33
|
17
|
|
Base Model + E-cadherin Dichotomized at 0.85
|
15–83
|
15
|
25
|
28
|
45
|
58
|
33
|
17
|
- Base Model includes standard diagnostic tests of lymph node evaluation and radiologic imaging (each coded as dichotomous positive versus negative). Each of the other models includes standard diagnostic tests and cellular membrane E-cadherin expression measured by immunohistochemistry in primary tumor cancer cells on a continuous average intensity scale (0–3), then modeled as continuous or dichotomized at the indicated cut point (if dichotomized, then coded as dichotomous EMT positive versus EMT negative). For all dichotomous predictors, a positive result means evidence supporting detachment of cancer cells from the primary tumor and a negative result means no evidence of detachment. Each model is a Cox proportional hazards models of time from cancer diagnosis to all-cause mortality, censored at 5 years after diagnosis. 62 subjects died within 5 years of diagnosis
